Tech Company Financing Transactions
Angstrom Bio Funding Round
GreyBird Ventures and private investors participated in a $3 million funding round for Angstrom Bio. The round was announced by the company on 6/18/2021.
Transaction Overview
Company Name
Announced On
6/18/2021
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Investors
GreyBird Ventures (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1108 Lavaca St. 110-329
Austin, TX 78701
USA
Austin, TX 78701
USA
Phone
Website
Email Address
Overview
We are Revolutionizing Diagnostics using the Tremendous Power of Amplicon Sequencing and machine learning. Our Goal is to Maximize the Reach of Amplicon Sequencing Diagnostics to Save, to Prolong and to Improve Human Lives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Carlos Santos
Chief Operating Officer
Jonathan Feldmann
Chief Scientific Officer
David States
VP - Bus. Development
Forrest Cox
VP - R & D
Josue Moran
Browse more venture capital transactions:
Prev: 6/18/2021: Anduril Industries venture capital transaction
Next: 6/18/2021: Circle Pharma venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs